Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tomography, Optical Coherence | 8 | 2017 | 88 | 1.270 |
Why?
|
Macular Edema | 3 | 2022 | 21 | 1.190 |
Why?
|
Fluorescein Angiography | 8 | 2017 | 57 | 1.170 |
Why?
|
Fovea Centralis | 3 | 2017 | 11 | 0.880 |
Why?
|
Choroid Diseases | 1 | 2022 | 6 | 0.860 |
Why?
|
Lymphoma | 1 | 2022 | 116 | 0.810 |
Why?
|
Retinal Vessels | 3 | 2017 | 74 | 0.740 |
Why?
|
Orbital Neoplasms | 2 | 2014 | 21 | 0.600 |
Why?
|
Cataract Extraction | 1 | 2018 | 127 | 0.560 |
Why?
|
Cataract | 1 | 2018 | 134 | 0.550 |
Why?
|
Diabetes Complications | 1 | 2018 | 249 | 0.540 |
Why?
|
Varicose Veins | 1 | 2015 | 11 | 0.500 |
Why?
|
Orbit | 1 | 2015 | 30 | 0.500 |
Why?
|
Retinoblastoma | 3 | 2020 | 26 | 0.460 |
Why?
|
Esophageal Neoplasms | 1 | 2014 | 150 | 0.450 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2014 | 138 | 0.450 |
Why?
|
Eye Diseases | 1 | 2013 | 38 | 0.450 |
Why?
|
Optic Disk | 1 | 2013 | 37 | 0.440 |
Why?
|
Optic Nerve | 1 | 2013 | 55 | 0.440 |
Why?
|
Adenocarcinoma | 1 | 2014 | 475 | 0.390 |
Why?
|
Fluconazole | 1 | 2010 | 26 | 0.370 |
Why?
|
Antifungal Agents | 1 | 2010 | 108 | 0.350 |
Why?
|
Choroid Neoplasms | 2 | 2017 | 20 | 0.290 |
Why?
|
Capillaries | 2 | 2017 | 105 | 0.280 |
Why?
|
Retinal Neoplasms | 2 | 2017 | 22 | 0.280 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 2223 | 0.270 |
Why?
|
Fundus Oculi | 2 | 2017 | 33 | 0.240 |
Why?
|
Retina | 2 | 2017 | 252 | 0.240 |
Why?
|
Humans | 21 | 2022 | 68618 | 0.220 |
Why?
|
Melanoma | 2 | 2017 | 335 | 0.220 |
Why?
|
Choroid | 1 | 2022 | 22 | 0.210 |
Why?
|
Retinal Dystrophies | 1 | 2022 | 4 | 0.210 |
Why?
|
Ophthalmic Solutions | 1 | 2022 | 39 | 0.210 |
Why?
|
Retinitis Pigmentosa | 1 | 2022 | 17 | 0.210 |
Why?
|
Integrins | 1 | 2022 | 115 | 0.200 |
Why?
|
Glaucoma | 2 | 2014 | 50 | 0.200 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 110 | 0.200 |
Why?
|
Healthy Volunteers | 2 | 2017 | 78 | 0.180 |
Why?
|
Male | 13 | 2020 | 37321 | 0.180 |
Why?
|
Brachytherapy | 2 | 2017 | 79 | 0.170 |
Why?
|
Equipment Design | 2 | 2017 | 500 | 0.170 |
Why?
|
Retinal Diseases | 2 | 2016 | 40 | 0.160 |
Why?
|
Antihypertensive Agents | 2 | 2014 | 498 | 0.160 |
Why?
|
Uveal Neoplasms | 1 | 2017 | 16 | 0.150 |
Why?
|
Optical Imaging | 1 | 2017 | 46 | 0.140 |
Why?
|
Middle Aged | 6 | 2017 | 21147 | 0.140 |
Why?
|
Intraocular Pressure | 2 | 2014 | 143 | 0.140 |
Why?
|
Prospective Studies | 3 | 2022 | 3705 | 0.140 |
Why?
|
Child, Preschool | 4 | 2020 | 3187 | 0.130 |
Why?
|
Female | 10 | 2020 | 38074 | 0.130 |
Why?
|
Radiation Injuries | 1 | 2016 | 97 | 0.130 |
Why?
|
Xanthogranuloma, Juvenile | 1 | 2015 | 4 | 0.130 |
Why?
|
Valsalva Maneuver | 1 | 2015 | 10 | 0.130 |
Why?
|
Iris Diseases | 1 | 2015 | 8 | 0.130 |
Why?
|
Hamartoma | 1 | 2015 | 24 | 0.130 |
Why?
|
Incidental Findings | 1 | 2015 | 42 | 0.120 |
Why?
|
Multimodal Imaging | 1 | 2015 | 62 | 0.120 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 1140 | 0.120 |
Why?
|
Image Enhancement | 1 | 2015 | 143 | 0.120 |
Why?
|
Accidents, Traffic | 1 | 2015 | 109 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 446 | 0.120 |
Why?
|
Retinal Pigment Epithelium | 1 | 2015 | 145 | 0.110 |
Why?
|
Actinomycetales Infections | 1 | 2013 | 2 | 0.110 |
Why?
|
Orbital Cellulitis | 1 | 2013 | 2 | 0.110 |
Why?
|
Arcanobacterium | 1 | 2013 | 2 | 0.110 |
Why?
|
Retinal Artery Occlusion | 1 | 2013 | 7 | 0.110 |
Why?
|
Eye Infections, Bacterial | 1 | 2013 | 15 | 0.110 |
Why?
|
Rhabdomyosarcoma | 1 | 2013 | 36 | 0.110 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 201 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 468 | 0.110 |
Why?
|
Biopsy | 1 | 2014 | 540 | 0.110 |
Why?
|
Clinical Trials as Topic | 2 | 2014 | 848 | 0.100 |
Why?
|
Palliative Care | 1 | 2014 | 271 | 0.100 |
Why?
|
Reproducibility of Results | 1 | 2017 | 2077 | 0.100 |
Why?
|
Coccidioidomycosis | 1 | 2010 | 6 | 0.090 |
Why?
|
Voriconazole | 1 | 2010 | 11 | 0.090 |
Why?
|
Retreatment | 1 | 2010 | 59 | 0.090 |
Why?
|
Infant | 4 | 2020 | 2891 | 0.090 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 137 | 0.090 |
Why?
|
Triazoles | 1 | 2010 | 43 | 0.090 |
Why?
|
Patient Selection | 1 | 2014 | 592 | 0.090 |
Why?
|
Young Adult | 2 | 2017 | 5717 | 0.090 |
Why?
|
Administration, Oral | 1 | 2010 | 411 | 0.080 |
Why?
|
Pyrimidines | 1 | 2010 | 178 | 0.080 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 567 | 0.080 |
Why?
|
Risk Factors | 1 | 2018 | 5731 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 1745 | 0.070 |
Why?
|
Aged | 4 | 2017 | 14862 | 0.060 |
Why?
|
Adult | 3 | 2017 | 21403 | 0.060 |
Why?
|
Visual Acuity | 2 | 2016 | 236 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2010 | 2550 | 0.050 |
Why?
|
Usher Syndromes | 1 | 2022 | 5 | 0.050 |
Why?
|
Adolescent | 4 | 2017 | 8912 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2022 | 24 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2022 | 7277 | 0.050 |
Why?
|
Molecular Chaperones | 1 | 2022 | 81 | 0.050 |
Why?
|
Antigens, Neoplasm | 1 | 2022 | 132 | 0.050 |
Why?
|
Cytoskeletal Proteins | 1 | 2022 | 108 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2010 | 7029 | 0.050 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2022 | 120 | 0.050 |
Why?
|
Child | 3 | 2017 | 6405 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 230 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2022 | 370 | 0.040 |
Why?
|
Subretinal Fluid | 1 | 2016 | 3 | 0.040 |
Why?
|
Artifacts | 1 | 2017 | 125 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2016 | 125 | 0.030 |
Why?
|
Infusions, Intra-Arterial | 1 | 2016 | 27 | 0.030 |
Why?
|
Vincristine | 1 | 2016 | 44 | 0.030 |
Why?
|
Etoposide | 1 | 2016 | 64 | 0.030 |
Why?
|
Carboplatin | 1 | 2016 | 59 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2016 | 215 | 0.030 |
Why?
|
South Carolina | 1 | 2022 | 2752 | 0.030 |
Why?
|
Microscopy, Acoustic | 1 | 2015 | 4 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2015 | 191 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2017 | 1046 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2014 | 218 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2013 | 55 | 0.030 |
Why?
|
Vision Disorders | 1 | 2013 | 94 | 0.030 |
Why?
|
Ischemia | 1 | 2013 | 229 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 649 | 0.020 |
Why?
|
Drug and Narcotic Control | 1 | 2010 | 15 | 0.020 |
Why?
|
Drug Approval | 1 | 2010 | 50 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 951 | 0.020 |
Why?
|
Disease Progression | 1 | 2013 | 1038 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2017 | 4848 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 1026 | 0.020 |
Why?
|
Time Factors | 1 | 2013 | 4655 | 0.020 |
Why?
|
Animals | 1 | 2010 | 20881 | 0.010 |
Why?
|